Pharmacokinetics and bronchial diffusion of single daily dose amikacin in cystic fibrosis patients

Journal of Antimicrobial Chemotherapy

Volumn 39, Issue 3, 1997, Pages 431-433

  Canis, F ^a   Husson, M O ^a   Turck, D ^a   Vic, P ^a   Launay, V ^a   Ategbo, S ^a   Vincent, A ^a   Courcol, R J ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN;

ADOLESCENT; ADULT; ARTICLE; BRONCHUS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIFFUSION; DRUG CLEARANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG DIFFUSION; MALE; SPUTUM; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AMIKACIN; BRONCHI; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DIFFUSION; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HALF-LIFE; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; SPUTUM;

EID: 0030960502     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/39.3.431     Document Type: Article

References (10)

1. Maller, R., Isakson, B., Nilsson, L. & Sören, L. (1988). A study of amikacin given once versus twice daily in serious infections. Journal of Antimicrobial Chemotherapy 22, 75-9.
2. Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Eben, S. & Craig, W. A. (1988). Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. Journal of Infectious Diseases 158, 831-47.
3. Sawchuck, R. J., Zaske, D. E., Cipolle, R. J., Wargin, W. A. & Strate, R. G. (1977). Kinetic model for gentamicin dosing with the use of individual patient parameters. Clinical Pharmacology and Therapeutics 21, 362-9.
4. Kafetzis, D. A., Sianidou, L., Vlachos, E., Davros, J., Baïramis, T., Papandreou, Y. et al. (1991). Clinical and pharmacokinetic study of a single daily dose of amikacin in paediatric patients with severe Gram-negative infections. Journal of Antimicrobial Chemotherapy 27, Suppl. C, 105-12.
5. Vogelstein, B., Kowarski, A. & Lietman, P. S. (1977). The pharmacokinetics of amikacin in children. Journal of Pediatrics 91, 333-9.
6. Levy, J., Baran, D. & Klastersky, J. (1982). Comparative study of the antibacterial activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis. Journal of Antimicrobial Chemotherapy 10, 227-34.
7. Finkelstein, E. & Hall, K. (1979). Aminoglycoside clearance in patients with cystic fibrosis. Journal of Pediatrics 94, 163-4.
8. Hanberger, H. (1992). Pharmacodynamic effects of antibiotics. Studies on bacterial morphology, initial killing, postantibiotic effect and effective regrowth time. Scandinavian Journal of Infectious Diseases, Suppl, 81, 1-52.
9. Mombelli, G., Coppens, L., Thys, J. P. & Klastersky, J. (1981). Anti-Pseudomonas activity in bronchial secretions of patients receiving amikacin or tobramcyin as a continuous infusion. Antimicrobial Agents and Chemotherapy 19, 72-5.
10. Autret, E., Marchand, S., Breteau, M. & Grenier, B. (1986). Pharmacokinetics of amikacin in cystic fibrosis: a study of bronchial diffusion. European Journal of Clinical Pharmacology 31, 79-83.